Literature DB >> 28216084

Vitamin D supplementation guidelines.

Pawel Pludowski1, Michael F Holick2, William B Grant3, Jerzy Konstantynowicz4, Mario R Mascarenhas5, Afrozul Haq6, Vladyslav Povoroznyuk7, Nataliya Balatska7, Ana Paula Barbosa5, Tatiana Karonova8, Ema Rudenka9, Waldemar Misiorowski10, Irina Zakharova11, Alena Rudenka12, Jacek Łukaszkiewicz13, Ewa Marcinowska-Suchowierska14, Natalia Łaszcz15, Pawel Abramowicz4, Harjit P Bhattoa16, Sunil J Wimalawansa17.   

Abstract

Research carried out during the past two-decades extended the understanding of actions of vitamin D, from regulating calcium and phosphate absorption and bone metabolism to many pleiotropic actions in organs and tissues in the body. Most observational and ecological studies report association of higher serum 25-hydroxyvitamin D [25(OH)D] concentrations with improved outcomes for several chronic, communicable and non-communicable diseases. Consequently, numerous agencies and scientific organizations have developed recommendations for vitamin D supplementation and guidance on optimal serum 25(OH)D concentrations. The bone-centric guidelines recommend a target 25(OH)D concentration of 20ng/mL (50nmol/L), and age-dependent daily vitamin D doses of 400-800IU. The guidelines focused on pleiotropic effects of vitamin D recommend a target 25(OH)D concentration of 30ng/mL (75nmol/L), and age-, body weight-, disease-status, and ethnicity dependent vitamin D doses ranging between 400 and 2000IU/day. The wise and balanced choice of the recommendations to follow depends on one's individual health outcome concerns, age, body weight, latitude of residence, dietary and cultural habits, making the regional or nationwide guidelines more applicable in clinical practice. While natural sources of vitamin D can raise 25(OH)D concentrations, relative to dietary preferences and latitude of residence, in the context of general population, these sources are regarded ineffective to maintain the year-round 25(OH)D concentrations in the range of 30-50ng/mL (75-125nmol/L). Vitamin D self-administration related adverse effects, such as hypercalcemia and hypercalciuria are rare, and usually result from taking extremely high doses of vitamin D for a prolonged time.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  25(OH)D; Extra-skeletal effects; Global; Pleiotropic; Recommendations; Vitamin D

Mesh:

Substances:

Year:  2017        PMID: 28216084     DOI: 10.1016/j.jsbmb.2017.01.021

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  133 in total

1.  Ethnic Variations in Serum 25(OH)D Levels and Bone Ultrasound Attenuation Measurements in Blacks and Whites.

Authors:  Rosario Sakamoto; D Thorpe; R Knutsen; L Beeson; S Knutsen
Journal:  J Racial Ethn Health Disparities       Date:  2017-06-21

Review 2.  Steroid Hormone Vitamin D: Implications for Cardiovascular Disease.

Authors:  Linda L Demer; Jeffrey J Hsu; Yin Tintut
Journal:  Circ Res       Date:  2018-05-25       Impact factor: 17.367

3.  Adherence to Vitamin D Intake Guidelines in the United States.

Authors:  Alan E Simon; Katherine A Ahrens
Journal:  Pediatrics       Date:  2020-05-18       Impact factor: 7.124

Review 4.  Chronic kidney disease and vitamin D metabolism in human bone marrow-derived MSCs.

Authors:  Shuanhu Zhou; Julie Glowacki
Journal:  Ann N Y Acad Sci       Date:  2017-08       Impact factor: 5.691

5.  Serum active 1,25(OH)2D, but not inactive 25(OH)D vitamin D levels are associated with cardiometabolic and cardiovascular disease risk in psoriasis.

Authors:  Martin P Playford; Amit K Dey; Claudia Zierold; Aditya A Joshi; Frank Blocki; Fabrizio Bonelli; Justin A Rodante; Charlotte L Harrington; Joshua P Rivers; Youssef A Elnabawi; Marcus Y Chen; Mark A Ahlman; Heather L Teague; Nehal N Mehta
Journal:  Atherosclerosis       Date:  2019-08-17       Impact factor: 5.162

Review 6.  Targeted 25-hydroxyvitamin D concentration measurements and vitamin D3 supplementation can have important patient and public health benefits.

Authors:  William B Grant; Fatme Al Anouti; Meis Moukayed
Journal:  Eur J Clin Nutr       Date:  2020-01-29       Impact factor: 4.016

7.  Risks of the 'Sunshine pill' - a case of hypervitaminosis D.

Authors:  Sebastien Ellis; Georgios Tsiopanis; Tanuj Lad
Journal:  Clin Med (Lond)       Date:  2018-08       Impact factor: 2.659

8.  Association of free vitamin D3 concentrations and asthma treatment failures in the VIDA Trial.

Authors:  John J Lima; Mario Castro; Tonya S King; Jason E Lang; Victor E Ortega; Stephen P Peters; Loren C Denlinger; Elliot Israel; Christine A Sorkness; Michael E Wechsler; Sally E Wenzel; Lewis J Smith
Journal:  Ann Allergy Asthma Immunol       Date:  2018-06-14       Impact factor: 6.347

9.  Vitamin D supplementation does not enhance resistance training-induced gains in muscle strength and lean body mass in vitamin D deficient young men.

Authors:  Lauri Savolainen; Saima Timpmann; Martin Mooses; Evelin Mäestu; Luule Medijainen; Lisette Tõnutare; Frederik Ross; Märt Lellsaar; Eve Unt; Vahur Ööpik
Journal:  Eur J Appl Physiol       Date:  2021-04-05       Impact factor: 3.078

10.  COVID-19 Disease Severity and Death in Relation to Vitamin D Status among SARS-CoV-2-Positive UAE Residents.

Authors:  Habiba AlSafar; William B Grant; Rafiq Hijazi; Maimunah Uddin; Nawal Alkaabi; Guan Tay; Bassam Mahboub; Fatme Al Anouti
Journal:  Nutrients       Date:  2021-05-19       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.